+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AliveCor Inc - Product Pipeline Analysis, 2021 Update

  • PDF Icon

    Company Profile

  • 30 Pages
  • June 2021
  • GlobalData
  • AliveCor Inc
  • ID: 5367317
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AliveCor Inc (AliveCor) is a medical device and artificial intelligence company that develops and manufactures ECG hardware and software for mobile devices. The company provides Kardia, an AI enabled platform to help clinicians manage patients for the detection of atrial fibrillation and normal sinus rhythm in an ECG. It offers KardiaMobile and KardiaBand applications. AliveCor provides portable device, early detection, immediate feedback and convenient short-term and long-term self-monitoring solutions. The company offers key clinical validation studies that include arrhythmia assessment, early detection, post-ablation and post-surgery. AliveCor is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AliveCor Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date

Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

AliveCor Inc Company Overview
  • AliveCor Inc Company Snapshot
  • AliveCor Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AliveCor Inc - Pipeline Analysis Overview
  • AliveCor Inc - Key Facts
  • AliveCor Inc - Major Products and Services
  • AliveCor Inc Pipeline Products by Development Stage

AliveCor Inc Pipeline Products Overview
  • Kardia AI V2
  • Kardia AI V2 Product Overview
  • KardiaK Software
  • KardiaK Software Product Overview
  • KardiaMobile - Anticoagulant Monitoring
  • KardiaMobile - Anticoagulant Monitoring Product Overview
  • KardiaMobile - EKG Interpretation
  • KardiaMobile - EKG Interpretation Product Overview
  • KardiaMobile - Heart Rate Variability
  • KardiaMobile - Heart Rate Variability Product Overview
  • KardiaMobile - Pediatric Patients
  • KardiaMobile - Pediatric Patients Product Overview
  • KardiaMobile - QT Interval Screening
  • KardiaMobile - QT Interval Screening Product Overview
  • KardiaMobile - ST Elevation Screening
  • KardiaMobile - ST Elevation Screening Product Overview

AliveCor Inc - Key CompetitorsAliveCor Inc - Key Employees
AliveCor Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Recent Developments
  • AliveCor Inc, Recent Developments
  • May 21, 2021: ITC formally commences investigation into Apple Watch infringement of AliveCor patents
  • Nov 18, 2020: Omron strengthens engagement with AliveCor with series E investment, reinforces cross-company alliance for remote cardiovascular condition management
  • May 06, 2020: AliveCor partners with The Clifford Lab at Emory University and Georgia Institute of Technology
  • Apr 23, 2020: AliveCor and OMRON announce alivecor and omron announce global strategic alliance for comprehensive remote cardiovascular monitoring
  • Feb 19, 2020: AliveCor receives approval to launch KardiaMobile in Mexico
  • Oct 30, 2019: AliveCor and Huami partner to deliver the next generation of medical wearables
  • Aug 30, 2019: KardiaMobile 6L offers world's first FDA -cleared and CE-marked, six-lead personal ECG device based on your smartphone
  • Jul 24, 2019: AliveCor appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board
  • May 13, 2019: FDA grants first ever clearance for Six-Lead Personal ECG Device
  • Apr 23, 2019: FDA grants first-ever clearances to detect bradycardia and tachycardia on a personal ECG Device

  • Methodology
  • About the Publisher

List of Tables
  • AliveCor Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AliveCor Inc Pipeline Products by Equipment Type
  • AliveCor Inc Pipeline Products by Indication
  • AliveCor Inc, Key Facts
  • AliveCor Inc, Major Products and Services
  • AliveCor Inc Number of Pipeline Products by Development Stage
  • AliveCor Inc Pipeline Products Summary by Development Stage
  • Kardia AI V2 - Product Status
  • Kardia AI V2 - Product Description
  • KardiaK Software - Product Status
  • KardiaK Software - Product Description
  • KardiaMobile - Anticoagulant Monitoring - Product Status
  • KardiaMobile - Anticoagulant Monitoring - Product Description
  • KardiaMobile - EKG Interpretation - Product Status
  • KardiaMobile - EKG Interpretation - Product Description
  • KardiaMobile - Heart Rate Variability - Product Status
  • KardiaMobile - Heart Rate Variability - Product Description
  • KardiaMobile - Pediatric Patients - Product Status
  • KardiaMobile - Pediatric Patients - Product Description
  • KardiaMobile - QT Interval Screening - Product Status
  • KardiaMobile - QT Interval Screening - Product Description
  • KardiaMobile - ST Elevation Screening - Product Status
  • KardiaMobile - ST Elevation Screening - Product Description

AliveCor Inc, Key Employees
  • AliveCor Inc, Subsidiaries
  • Glossary

List of Figures
  • AliveCor Inc Pipeline Products by Equipment Type
  • AliveCor Inc Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ECG Scanning & Medical Services, Inc.
  • Azumio Inc
  • Qardio Inc